Literature DB >> 28018015

Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times.

Yanxun Xu1, Peter Müller2, Abdus S Wahed3, Peter F Thall4.   

Abstract

We analyze a dataset arising from a clinical trial involving multi-stage chemotherapy regimes for acute leukemia. The trial design was a 2 × 2 factorial for frontline therapies only. Motivated by the idea that subsequent salvage treatments affect survival time, we model therapy as a dynamic treatment regime (DTR), that is, an alternating sequence of adaptive treatments or other actions and transition times between disease states. These sequences may vary substantially between patients, depending on how the regime plays out. To evaluate the regimes, mean overall survival time is expressed as a weighted average of the means of all possible sums of successive transitions times. We assume a Bayesian nonparametric survival regression model for each transition time, with a dependent Dirichlet process prior and Gaussian process base measure (DDP-GP). Posterior simulation is implemented by Markov chain Monte Carlo (MCMC) sampling. We provide general guidelines for constructing a prior using empirical Bayes methods. The proposed approach is compared with inverse probability of treatment weighting, including a doubly robust augmented version of this approach, for both single-stage and multi-stage regimes with treatment assignment depending on baseline covariates. The simulations show that the proposed nonparametric Bayesian approach can substantially improve inference compared to existing methods. An R program for implementing the DDP-GP-based Bayesian nonparametric analysis is freely available at https://www.ma.utexas.edu/users/yxu/.

Entities:  

Keywords:  Dependent Dirichlet process; G-Computation; Gaussian process; In-verse probability of treatment weighting; Markov chain Monte Carlo

Year:  2016        PMID: 28018015      PMCID: PMC5175473          DOI: 10.1080/01621459.2015.1086353

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  27 in total

1.  Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.

Authors:  Jared K Lunceford; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

3.  Gaussian process functional regression modeling for batch data.

Authors:  J Q Shi; B Wang; R Murray-Smith; D M Titterington
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

4.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

5.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

6.  Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.

Authors:  E H Estey; P F Thall; S Pierce; J Cortes; M Beran; H Kantarjian; M J Keating; M Andreeff; E Freireich
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

7.  Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.

Authors:  Peter F Thall; Christopher Logothetis; Lance C Pagliaro; Sijin Wen; Melissa A Brown; Dallas Williams; Randall E Millikan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

8.  New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Ying-Qi Zhao; Donglin Zeng; Eric B Laber; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

9.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

10.  Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.

Authors:  Lu Wang; Andrea Rotnitzky; Xihong Lin; Randall E Millikan; Peter F Thall
Journal:  J Am Stat Assoc       Date:  2012-06       Impact factor: 5.033

View more
  11 in total

1.  Bayesian non-parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantation.

Authors:  Yanxun Xu; Peter F Thall; William Hua; Borje S Andersson
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-12-16       Impact factor: 1.864

2.  A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes.

Authors:  Thomas A Murray; Ying Yuan; Peter F Thall
Journal:  J Am Stat Assoc       Date:  2018-10-08       Impact factor: 5.033

3.  Precision Medicine.

Authors:  Michael R Kosorok; Eric B Laber
Journal:  Annu Rev Stat Appl       Date:  2019-03       Impact factor: 5.810

4.  Bayesian Semiparametric Joint Regression Analysis of Recurrent Adverse Events and Survival in Esophageal Cancer Patients.

Authors:  Juhee Lee; Peter F Thall; Steven H Lin
Journal:  Ann Appl Stat       Date:  2019-04-10       Impact factor: 2.083

5.  Bayesian population finding with biomarkers in a randomized clinical trial.

Authors:  Satoshi Morita; Peter Müller
Journal:  Biometrics       Date:  2017-03-03       Impact factor: 2.571

6.  Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.

Authors:  Rebecca Hager; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrics       Date:  2018-05-18       Impact factor: 2.571

7.  Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis.

Authors:  Bin Huang; Tingting Qiu; Chen Chen; Yin Zhang; Michael Seid; Dan Lovell; Hermine I Brunner; Esi M Morgan
Journal:  RMD Open       Date:  2020-01

8.  Bayesian nonparametric statistics: A new toolkit for discovery in cancer research.

Authors:  Peter F Thall; Peter Mueller; Yanxun Xu; Michele Guindani
Journal:  Pharm Stat       Date:  2017-07-04       Impact factor: 1.894

9.  Bayesian Nonparametric Policy Search with Application to Periodontal Recall Intervals.

Authors:  Qian Guan; Brian J Reich; Eric B Laber; Dipankar Bandyopadhyay
Journal:  J Am Stat Assoc       Date:  2019-10-09       Impact factor: 5.033

10.  A Bayesian nonparametric approach to marginal structural models for point treatments and a continuous or survival outcome.

Authors:  Jason Roy; Kirsten J Lum; Michael J Daniels
Journal:  Biostatistics       Date:  2016-06-26       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.